FDA Approved: PITAVASTATIN — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for pitavastatin calcium (pitavastatin) under ANDA205932.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hyperlipidemia

Drugs mentioned

• PITAVASTATIN CALCIUM (PITAVASTATIN CALCIUM)

Snippet

SUPPL AP for PITAVASTATIN (PITAVASTATIN CALCIUM)